Cyclin D1 and retinoblastoma susceptibility gene alterations in non- small cell lung cancer

International Journal of Cancer

Volumn 75, Issue 2, 1998, Pages 187-192

  Marchetti, Antonio ^a   Doglioni, Claudio ^b   Barbareschi, Mattia ^c   Buttitta, Fiamma ^a   Pellegrini, Silvia ^a   Gaeta, Patrizia ^a   La Rocca, Roberto ^a   Merlo, Giorgio ^d   Chella, Antonio ^a   Angeletti, Carlo Alberto ^a   Palma, Paolo Dalla ^a   Bevilacqua, Generoso ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Hospital of Belluno   (Italy)

^c SANTA CHIARA HOSPITAL   (Italy)

^d ADVANCED BIOTECHNOLOGY CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MESSENGER RNA;

ARTICLE; CANCER GENETICS; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

CARCINOMA, NON-SMALL-CELL LUNG; CYCLIN D1; GENES, RETINOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; RNA, MESSENGER;

EID: 17144465526     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980119)75:2<187::AID-IJC4>3.0.CO;2-Q     Document Type: Article

References (32)

1. BARBARESCHI, M., GIRLANDO, S., MAURI, F.A., ARRIGONI, G., LAURINO, L., DALLA PALMA, P. and DOGLIONI, C., Tumor suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms. J. Pathol., 166, 343-350 (1992).
2. WAFI immunohistochemical expression. Int. J. Cancer (Pred. Oncol.) 74, 171-174 (1997).
3. BARTKOVA, J., LUKAS, J., STRAUSS, M. and BARTEK, J., Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncoyene, 10, 775-778 (1995).
4. BATES, S., PARRY, D., BONETTA, L., VOUSDEN, K., DICKSON, C. and PETERS, G., Absence of cyclin D/CDK complexes in cells lacking functional retinoblastoma protein. Oncogene, 9, 1633-1640 (1994).
5. BERENSON, J.R., KOGA, J., YANG, J., PEARL, J., HOLMES, E.C., FIGLIN, R. and THE LUNG CANCER STUDY GROUP, Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. Oncoqene, 5, 1343-1348 (1990).
6. BETTICHER, D.C., HEIGHWAY, J., HASLETON, P.S., ALTERMATT, H.J., RVDER, W.D.J., CERNY, T. and THATCHER, N., Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Brit. J. Cancer, 73, 294-300 (1996).
7. DEVOS, S., MILLER, C.W., TAKEUCHI, S., GOMBART, A.F., CHO, S.K. and KOEFFLER, H.P., Alterations of CDKN2 (p16) in non-small cell lung cancer. Gene Chromosomes Cancer, 14, 164-170 (1995).
8. DOGLIONI, C., CHIARELLI, C., MACRI, E., DEI TOS, A.P., MEGGIOLARO, E., DALLA PALMA, P. and BARBARESCHI, M., Cyclin D3 expression in human normal tissues and neoplasms. J. Pathol., (1997). (In press).
9. GALLIE, B.L., Retinoblastoma gene mutations in human cancer. N. Engl. J. Med., 330, 786-787 (1994).
10. GOUYER, V., GAZZERI, S., BRAMBILLA, E., BOLON, I., MORO, D., PERRON, P., BENABID, A.L. and BRAMBILLA, C., Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas. Int. J. Cancer, 58, 818-824 (1994).
11. HARBOUR, J.W., LAI, S.L., WHANG-PENG, J., GAZDAR, A.F. and MINNA, J.D., Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science, 241, 353-357 (1988).
12. 1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Development, 8, 1759-1771 (1994).
13. HIGASHIYAMA, M., DOI, O., KODAMA, K., YOKOUCHI, H. and TATEISHI, R., Retinoblastoma protein expression in lung cancer: an immunohistochemical analysis. Oncology, 51, 544-551 (1994).
14. 1 control. Cancer Res., 55, 4818-4823 (1995).
15. LUKAS, J., PAGANO, M., STASKOWA, G., DRAETTA, G. and BARTEK, J., Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumor cell lines. Oncogene, 9, 707-718 (1994).
16. MARCHETTI, A., BUTTITTA, F., PELLEGRINI, S., BERTACCA, G., CHELLA, A., CARNICELLI, V., TOGNONI, V., FILARDO, A., ANGELETTI, C.A. and BEVILACQUA, G., Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas. J. Pathol. 181, 178-182 (1997).
17. MARCHETTI, A., BUTTITTA, F., PELLEGRINI, S., DIELL, F., CAMPANI, D., CECCHETTI, D., MERLO, C., CALLAHAN, R. and BISTOCCHI, M., p53 mutations and histological type of invasive breast carcinoma. Cancer Res., 53, 4665-4669 (1993).
18. MARCHETTI, A., DOGLIONI, C., BARBARESCHI, M., BUTTITTA, F., PELLEGRINI, S., BERTACCA, G., CHELIA, A., MERLO, G., ANGELETTI, C. A., DALLA PALMA, P. and BEVILACQUA, G., p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene, 12, 1319-1324 (1996).
19. MATE, J., ARIZA, A., ARACIL, C., LOPEZ, D., ISAMAT, M., PEREZ-PITEIRA, J. and NAVAS-PALACIOS, J.J., Cyclin D1 overexpression in non-small cell lung carcinoma: correlation with Ki67 labelling index and poor cytoplasmic differentiation. J. Pathol., 180, 395-399 (1996).
20. MOUNTAIN, C.F., A new international staging system for lung cancer. Chest, 89, 225S-233S (1986).
21. 1 events and regulation of cell proliferation. Science, 246, 603-608 (1989).
22. PELOSIO, P., BARBARESCHI, M., BONOLDI, E., MARCHETTI, A., VERDERIO, P., CAFFO, O., BEVILACQUA, P., BORACCHI, P., BUTTITTA, F., BARBAZZA, R., DALLA PALMA, P. and GASPARINI, G., Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy. Ann. Oncol., 7, 695-703 (1996).
23. REISSMANN, P.T., KOGA, H., TAKAHHASHI, R., FIGLIN, R.A., HOLMES, C., PIANTADOSI, S., CORDON-CARDO, C. and SLAMON, D.J., Inactivation of the retinoblastoma susceptibility gene in non-small cell lung cancer. Oncogene, 8, 1913-1919 (1993).
24. SCHAUER, I.E., SIRIWARDANA, S., LANGAN, T.A. and SCLAFANI, R.A., Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer. Proc. nat. Acad. Sci.(Wash.), 91, 7827-7831 (1994).
25. SHAPIRO, G.I., EDWARDS, C.D., KOBZIK, L., GODLESKI, J., RICHARDS, W., SUGARBAKER, D.J. and ROLLINS, B.J., Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res., 55, 505-509 (1995).
26. 1 phase appears to be required for the development of neoplasia. Nature (Med.), 1, 1245-1246 (1995).
27. USUDA, H., SAITO, T., EMURA, I. and NAITO, M., Immunohistochemistry of cyclin D3 in pulmonary carcinomas. Virchows Archiv, 428, 159-163 (1996).
28. WEINBERG, R.A., The retinoblastoma protein and cell cycle control. Cell, 81, 323-330 (1995).
29. WORLD HEALTH ORGANIZATON, Histological typing of lung tumors. Amer. J. clin. Pathol., 77, 123-136 (1982).
30. XU, H.J., CAGLE, P.T., HU, S.H., LI, J. and BENEDICT, W.F., Altered retinoblastoma and p53 status in non-small cell carcinoma of the lung: potential synergistic effects on prognosis. Clin. Cancer Res., 2, 1169-1176 (1996).
31. XU, H.J., QUINLAN, D.C., DAVIDSON, A.G., HU, S.X., SUMMERS, C.L., LI, J. and BENEDICT, W.F., Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma. J. nat. Cancer Inst., 86, 695-699 (1994).
32. YOKOTA, J., AKIJAMA, T., FUNG, Y.T., BENEDICT, W.F., NAMBA, Y., HANAOKA, M. and WADA, M., Altered expression of the retinoblastoma gene in small cell lung carcinoma of the lung. Oncogene, 3, 471-475 (1988).